Completed A Multicenter, Open-label, Dose-finding Trial of OPC-41061 to Investigate Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety in Patients With Carcinomatous Edema (Phase 2) NCT01684202 Conditions Carcinomatous Edema Locations Kansai Region, Japan View Trial Details